MRK Latest Headlines

FDA launches pilot program that aims to speed the time to first-in-human drug trials

at seekingalpha.com (Tue, 15-Sep 11:26 AM)

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

at www.tipranks.com (Mon, 14-Sep 9:46 PM)

Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial

at seekingalpha.com (Sun, 13-Sep 1:23 PM)

The Week That Was, The Week Ahead: Macro and Markets, September 13

at www.tipranks.com (Sun, 13-Sep 4:27 AM)

DBS Keeps Their Buy Rating on Merck & Company (MRK)

at www.tipranks.com (Fri, 11-Sep 12:55 PM)

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

at www.tipranks.com (Fri, 11-Sep 4:20 AM)

MRK Breaks New Ground with Positive Phase 3 Results for mRNA Cancer Vaccine Combination in Melanoma

Market Chameleon (Wed, 19-Aug 11:08 AM)

Merck and Moderna Set New Benchmark: Individualized mRNA-Cancer Therapy Shows Statistically Significant Results in Melanoma

Market Chameleon (Wed, 19-Aug 7:07 AM)

MRK Iron Condor Can Make 34% in Next 7 Days

Market Chameleon (Wed, 19-Aug 10:56 AM)

Merck Raises Full-Year Outlook After Robust Q2 Growth and Regulatory Wins Across Pipeline

Market Chameleon (Tue, 4-Aug 7:16 AM)

Merck Declares $0.85 Dividend for Q4 2026, Emphasizing Commitment to Shareholders and Long-Term Growth

Market Chameleon (Thu, 30-Jul 7:14 AM)

Merck Unveils Promising Once-Weekly and Monthly HIV Treatments—Key Data to Be Presented at AIDS 2026

Market Chameleon (Wed, 15-Jul 7:29 AM)

Bullish On MRK? You Might Want To Consider This Credit Put Spread Expiring in 21 Days

Market Chameleon (Thu, 2-Jul 1:09 PM)

Bullish On MRK? You Might Want To Consider This Credit Put Spread Expiring in 10 Days

Market Chameleon (Fri, 26-Jun 12:26 PM)

Merck’s Tulisokibart Marks First Anti-TL1A Success in Phase 3 Ulcerative Colitis Study—Phase 3 Results Show Promise for Immuno-Fibrosis Treatment

Market Chameleon (Mon, 22-Jun 7:53 AM)